• Luminal Gastroenterology
• 31 min
  1. Novel treatments for GI malignancies

  • Prof. Bert H. O'Neil
• 40 min
  2. The spectrum of GERD implications for assessment and management

  • Prof. Eamonn M. M. Quigley
• 54 min
  3. Oro-pharyngeal and esophageal motility and dysmotility

  • Dr. John E. Pandolfino
• 55 min
  4. Eosinophilic esophagitis and other non-reflux esophageal disorders

  • Prof. David Katzka
• 39 min
  5. Disorders of gastric function: gastroparesis and functional dyspepsia 1

  • Dr. Braden Kuo
• 17 min
  6. Disorders of gastric function: gastroparesis and functional dyspepsia 2

  • Dr. Braden Kuo
• 48 min
  7. Acid-peptic diseases of the stomach and duodenum including Helicobacter pylori and NSAIDs

  • Prof. Sheila Crowe
• 48 min
  8. Gastric cancer, gastritis and the role of H. pylori

  • Prof. Anthony Axon
• 48 min
  9. Celiac disease

  • Prof. Ciaran Kelly
• 43 min
  10. IBD for the non-gastroenterologist

  • Prof. Sunanda Kane
• 34 min
  11. The enteric microbiota in health and disease

  • Dr. Francisco Guarner
• 45 min
  12. Colorectal cancer and hereditary colon cancer syndromes

  • Prof. Carol A. Burke
• 39 min
  13. The spectrum of GI ischemia 1

  • Prof. Lawrence J. Brandt
• 31 min
  14. The spectrum of Gl ischemia 2

  • Prof. Lawrence J. Brandt
• 41 min
  15. Constipation and defecation disorders

  • Prof. Satish S. C. Rao
• 40 min
  16. Diverticular disease of the colon

  • Dr. Dale Vimalachandran
• 73 min
  17. Irritable bowel syndrome (IBS)

  • Prof. Eamonn M. M. Quigley
• 27 min
  18. Evidence-based management of non-variceal upper GI bleeding

  • Prof. Joseph J. Sung
• Hepatology
• 32 min
  19. Hepatitis B virus (HBV)

  • Prof. Marco Olivera-Martinez
• 26 min
  20. Hepatitis C - cure of infection

  • Prof. Mark Mailliard
• 46 min
  21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI

  • Prof. James H. Lewis
• 26 min
  22. Drug-induced liver injury: risk factors and drug development in DILI

  • Prof. James H. Lewis
• 39 min
  23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI

  • Prof. James H. Lewis
• 22 min
  24. Portal hypertension

  • Prof. John Reinus
• 55 min
  25. Portal hypertension: at the bedside

  • Dr. Clara Y. Tow
• 29 min
  26. The management of chronic liver disease, including transplantation 1

  • Prof. Timothy M. McCashland
• 21 min
  27. The management of chronic liver disease, including transplantation 2

  • Prof. Timothy M. McCashland
• 34 min
  28. Hereditary hemochromatosis: what have we learnt from population studies

  • Prof. John K. Olynyk
• 38 min
  29. Immune-mediated liver disease

  • Dr. Jenny Heathcote
• 51 min
  30. Alcoholic liver disease

  • Prof. Michael Lucey
• The Pancreas and Biliary Tree
• 46 min
  31. Acute pancreatitis

  • Prof. Davor Štimac
• 49 min
  32. Chronic pancreatitis

  • Prof. Christopher Forsmark
• 47 min
  33. Pancreatic cancer

  • Prof. Randall Brand
• 20 min
  34. The management of gallstones in relation to laparoscopic cholecystectomy and gallbladder dyskinesia

  • Prof. John Baillie
• Archived Lectures *These may not cover the latest advances in the field
• 52 min
  35. The management of other aspects of chronic liver disease, including transplantation

  • Prof. Timothy M. McCashland
• 38 min
  36. Chronic viral hepatitis B and C

  • Prof. Mark Mailliard
• 41 min
  37. Pancreatic cancer

  • Prof. Randall Brand
• 72 min
  38. Acute viral hepatitis

  • Prof. Geoffrey Dusheiko
• 33 min
  39. Diverticular disease

  • Dr. Charles Knowles
• 57 min
  40. The spectrum of gastrointestinal ischemia: 2010

  • Prof. Lawrence J. Brandt
• 51 min
  41. Acute pancreatitis

  • Prof. Davor Štimac

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Epidemiology of constipation in the US
3. Physician vs. patient's perception of constipation
4. Secondary causes of constipation
5. Primary causes of constipation
6. IBS-C vs. chronic constipation: symptoms
7. Pathophysiology of chronic constipation
8. The reasons for constipation
9. Evaluation of constipation
10. DRE protocol
11. Colon transit study
12. SmartPill: whole gut transit and motility
13. Management strategies for constipation
14. Traditional treatments for chronic constipation
15. PEG
16. Treatment satisfaction for chronic constipation
17. Effects of lubiprostone on bowel movements
18. Efficacy of linaclotide in chronic constipation
19. Prucalopride treatment - chronic constipation
20. Probiotics for treatment of constipation
21. What is dyssynergia?
22. Biofeedback on constipation (1)
23. Biofeedback on constipation (2)
24. Biofeedback effects on CSBM and dyssynergia
25. Long term outcome of biofeedback on CSBM
26. Conclusions
27. Pathophysiological-based treatment approach
28. Algorithm approach to constipation
29. Common defecation disorders
30. Solitary rectal ulcer syndrome (1)
31. Solitary rectal ulcer syndrome (2)
32. Solitary rectal ulcer syndrome (3)
33. Changes before and after biofeedback therapy
34. Other improvements due to biofeedback therapy
35. Changes in sigmoidoscopy
36. Rectocele
37. Management of rectocele
38. Take home message

Topics Covered

• Disorders of pelvic floor dysfunction such as constipation, solitary rectal ulcer syndrome and rectocle are very common and cause significant bowel symptoms and problems
• Common presentations, underlying mechanisms and diagnostic modalities
• Common approaches for treatment including biofeedback therapy

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Clinical Practice
• Metabolism & Nutrition

Therapeutic Areas:

• Gastroenterology & Nephrology

Talk Citation

Publication History

• Published on January 5, 2011

Financial Disclosures

• Prof. Satish S. C. Rao has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.